Live Breaking Biotech News and Articles

Biotech News Journal

Subscribe to Biotech News Journal: eMailAlertsEmail Alerts newslettersWeekly Newsletters
Get Biotech News Journal: homepageHomepage mobileMobile rssRSS facebookFacebook twitterTwitter linkedinLinkedIn


Top Stories

Marc Andreessen appeared on Charlie Rose last night. (The entire interview is embedded above). He gave Rose a primer on everything from Facebook and cloud computing to the mobile Web. But he also tells Rose: “I’m creating a fund.” Actually, Andreessen is creating it with his investing partner Ben Horowitz, and it will formalize the angel investing he has been doing on his own for the past several years. It will be called Andreessen Horowitz. From the transcript: Charlie Rose: Why are you doing this? Marc Andreessen: Because of the nature and the scale of the opportunities. We’re actually been investing ourselves with our own money for three years and we’ve invested in 36 — he and I invested together in 36 deals in three years so about one a month. Charlie Rose: Yeah, but I’ve read that you think that the normal investment for you to make, this may have been prefun... (more)

Introducing Agile: Hidden Benefits (and Some Challenges)

Our next presentation was by Stefan Meier, Associate Director, Software Development, Information Sciences Department at XDx. Xdx is a biotech company that relies on software and technology for their Molecular Diagnostic Technology. They assess patients who have had a heart transplant and whether they are likely to accept or reject the transplant. They are also working on a clinical study to provide the data to find correlations between genetics and pathology in disease/immune system-related areas. Prior to Agile & OutSystems - the development team was 5 developers and 2 SQA and 1 project manager using classical waterfall methods - with 3 Web-based EDC systems for clinical trials, 2 internally developed LIMS applications (1 FDA regulated), several custom query/reporting/maintenance applications and Excel spreadsheets for reporting. One key problem Stefan highlighted ... (more)

Bluenog Awarded 'Red Herring 100 North America'

Bluenog has announced that it has been selected as a winner of the Red Herring 100 North America Award. The Red Herring editorial team deployed a detailed process to whittle down a pool of 1,000 eligible, promising companies to 200 finalists. Ultimately, 100 winners were chosen and recognized as the top technology companies of 2009. Evaluations are made on both quantitative and qualitative criteria, such as financial performance, innovation, management, global strategy, and ecosystem integration. The winners, elite executives and venture capital leaders from North America, celebrated in San Diego from May 11-14, 2009. "Of the thousands of companies that have submitted their entries, we were tasked with choosing the technologies that are making the biggest impact this year," said Alex Vieux, publisher and CEO of Red Herring. "Bluenog is one of those exceptional comp... (more)

VIRTERA Wins SYS-CON Virtualization Conference Show Awards 2009

VIRTERA, a virtualization professional services and consulting firm, announced that it was awarded two first place show finishes from SYS-CON Events for its Virtual Desktop Financial Calculator and its Virtualization Infrastructure Platform Qualification (VIPQ) solution for the Pharmaceutical industry. SYS-CON Events offered all delegates at the 5th International Virtualization Conference & Expo 2009 East in New York, NY, the opportunity to cast their vote for their favorite virtualization technology provider in four competitive categories: Best Overall Virtualization Product Best Greener IT Product Best Server Virtualization Solution Best Management Solution VIRTERA received its first award in the category "Best Greener IT Product" for its virtual desktop financial calculator which assists clients in understanding the cash flow related to virtualized desktop environ... (more)

Technology Heroes Also Serve in Government

Great American technologists from academia and industry have always ensured our national security has the edge it needs, in peace, crisis and war. Academic Fredrick Terman (pictured) brought us radar and Silicon Valley. Edwin Land brought us overhead ISR. Gordon Moore ensured integrated circuits were accelerated into our community first. Scott McNealy drove security into Operating Systems. Bill Gates and Larry Ellison and a long list of other great IT leaders have also dedicated significant effort to the national security community in ways many will never know. Great technology heroes also serve in government.  Thanks to them government has been pioneering advances in secure cloud computing, biometrics, IT security, collaboration, geospatial, visualization, remote sensing and collaboration. Government IT leaders routinely contribute to our nation’s understanding of... (more)

TIBCO Spotfire in Life Sciences

Oracle Keynote at Cloud Expo October 19, 2009 - TIBCO Software announced a strategic push to extend its leadership position in the global life sciences market with the release of several research and clinical analysis solutions, including Integromics Biomarker Discovery 2.0 for TIBCO Spotfire, TIBCO Spotfire Lead Discovery 2.0, TIBCO Spotfire Pipeline Pilot Connector, and TIBCO Spotfire Clinical Graphics 2.0. These solutions deliver integrated informatics and analysis, are central to research & development efforts in the life sciences industry and can transform the process of bringing life-saving medicines to market. Access to actionable knowledge early in the commercialization process of a new drug can lead to better safety outcomes for patients, and better regulatory and commercial outcomes for the industry. The TIBCO Spotfire Enterprise Analytics Platform is de... (more)

Rider Revenge App Launches on Apple Store, Aims to Stop Distracted Driving

Madison, NJ, June 16, 2014 --(PR.com)-- Rider Revenge, the technology platform to reduce Distracted Driving, has announced the launch of their app’s prototype on Apple’s App Store. The launch comes on the heels of successfully closing the Company’s first round of crowd-funding. "The launch of our prototype on the Apple Store is a significant development milestone for our company," said Peter Gallagher, Founder & CEO of Rider Revenge. "During the last two months, we have gained tremendous momentum. We closed our round of funding on Kiva Zip with nearly 200 lenders. Then we finished development of our beta prototype of the app. User feedback is helping us to shape and progress the app toward a full commercial product later this year." The app is built on the company’s geo-specific, time-dependent mapping technology, called Crowd Spotting. The software collects the input... (more)

3 Steps to Impossible Dreams and Breakout Innovation

I spent a day last week at the Arizona Biotech Conference, sharing and learning about the amazing industry that’s forming in Arizona.  Who know that the #1 biotech IPO for 2013 was an Arizona firm?  I surely didn’t. I had the chance to see an approved synthetic heart (yep,we can all forget the Russian roulette of  that transplant list now.)  I say a new pacemaker/ defibrillator that is smaller than a stint as well as new monitoring devices that can be injected in a vein. Talk about micro! I was surrounded by breakout innovation. What a powerful experience and opportunity to model highly successful innovation. As I listened to one of the speakers, the head of the Arizona division of MedTronics, discuss innovation -  he said something that really struck home. “If you’re going to revolutionize, you have to start with a goal that seems impossible.” Wow.  How powerful is ... (more)

Trinity Biotech Announces the Launch of New Lyme Products for the European Market

DUBLIN, IRELAND -- (MARKET WIRE) -- 01/24/08 -- Trinity Biotech plc (NASDAQ: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announced the launch of its new Lyme Enzyme Immunoassay (EIA) products specifically designed for the European market. The new products, the Trinity Biotech EU Lyme IgG + VlsE EIA and the EU Lyme IgM EIA are designed for use as screening assays in clinical laboratories. They are qualitative serological tests for the detection of IgG and IgM antibodies to the most prevalent and clinically important Borrelia species in Europe, i.e. Borrerlia afzelii, Borrelia garinii, and Borrelia burgdorferi. The addition of VlsE to the product significantly boosts sensitivity of the assay. These new products complete Trinity Biotech's product offering for Lyme Disease in Europe, co... (more)

avVaa World Health Care Products, Inc. DRTV Campaign for Neuroskin(R) Psoriasis Relief Is on Schedule for August Launch

LUMBY, BC -- (Marketwire) -- 08/12/09 -- avVaa World Health Care Products Inc. (PINKSHEETS: AVVH), a global biotechnology company, manufacturer and distributor of nationally branded therapeutic, natural skin and health care products, is pleased to announce that the DRTV campaign is on schedule for the August media test. avVaa President & COO Lorie Campbell-Farley says, "We are very impressed with our DRTV spot, and we expect to launch it the week of August 24th, 2009." Neuroskin® will gain consumer confidence with back to back media repetition campaigns. This will generate consumer confidence, and an urgency to buy. Neuroskin® fills the consumer gap for a steroid-free solution for psoriasis, seborrheic dermatitis, acne and other skin irritations. It is doctor recommended, but no prescription is required. avVaa World Health Care is making things happen by creating a m... (more)

R&D Credit Coalition Commends House Small Business Committee for Hearing on How Expiring Tax Credits Will Impact U.S. Economy

WASHINGTON, Sept. 30 /PRNewswire-USNewswire/ -- The R&D Credit Coalition applauds the House Small Business Committee for meeting today to examine the impact that expiring tax credits, including the R&D tax credit, will have on small companies and the U.S. economy. The Coalition is urging Congress to act quickly to permanently extend and strengthen the R&D tax credit set to expire on December 31, 2009. President Obama, in a speech last week, laid out his national innovation strategy with research and development as a centerpiece, calling for a permanent R&D tax credit. "This is a tax credit that helps companies afford the often high costs of developing new ideas, new technologies, new products -- which means new jobs. And this tax incentive returns two dollars to the economy for every one dollar we spend," the President said. The following is a statement ... (more)